Benjamin Edwards’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.46M Buy
27,346
+279
+1% +$46.5K 0.04% 376
2026
Q2
$5.06M Sell
27,067
-2,173
-7% -$409K 0.05% 347
2026
Q1
$5.66M Sell
29,240
-442
-1% -$85.2K 0.06% 306
2025
Q4
$5.46M Sell
29,682
-3,104
-9% -$544K 0.06% 291
2025
Q3
$5.03M Buy
32,786
+468
+1% +$70.8K 0.06% 297
2025
Q2
$4.52M Buy
32,318
+4,822
+18% +$676K 0.06% 301
2025
Q1
$4.04M Sell
27,496
-542
-2% -$78.4K 0.06% 289
2024
Q4
$3.67M Sell
28,038
-1,898
-6% -$266K 0.05% 311
2024
Q3
$4.66M Buy
29,936
+23,269
+349% +$3.76M 0.07% 271
2024
Q2
$1.04M Sell
6,667
-767
-10% -$115K 0.2% 130
2024
Q1
$1.01M Hold
7,434
– – 0.2% 131
2023
Q4
$1M Sell
7,434
-3,384
-31% -$440K 0.22% 128
2023
Q3
$1.46M Buy
10,818
+1,692
+19% +$231K 0.35% 87
2023
Q2
$1.31M Buy
9,126
+171
+2% +$25.2K 0.3% 94
2023
Q1
$1.24M Sell
8,955
-1,702
-16% -$229K 0.3% 93
2022
Q4
$1.44M Buy
10,657
+1,363
+15% +$171K 0.38% 79
2022
Q3
$1.02M Buy
9,294
+929
+11% +$118K 0.31% 100
2022
Q2
$1.1M Buy
8,365
+1,152
+16% +$151K 0.32% 95
2022
Q1
$957K Buy
7,213
+3,181
+79% +$381K 0.28% 108
2021
Q4
$470K Buy
4,032
+3,543
+725% +$417K 0.15% 157
2021
Q3
$59K Buy
489
+339
+226% +$39.5K 0.04% 281
2021
Q2
$18K Hold
150
– – 0.01% 335
2021
Q1
$15K Hold
150
– – 0.01% 316
2020
Q4
$15K Hold
150
– – 0.01% 308
2020
Q3
$16K Hold
150
– – 0.01% 292
2020
Q2
$16K Hold
150
– – 0.01% 265
2020
Q1
$13K Buy
+150
New +$14.1K 0.01% 265

Other funds holding AZN

Benjamin Edwards's AZN Position: Q3 2026 in Review

Benjamin Edwards increased its AstraZeneca (AZN) stake by 1% in Q3 2026, buying an estimated $46.5K and bringing the position to 27,346 shares worth $4.46M. The position accounts for 0.04% of the portfolio, ranked #376.

Benjamin Edwards first reported a position in AZN in Q1 2020 and has held it in 27 quarters since. The position peaked at $5.66M in Q1 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Benjamin Edwards held 27,346 shares of AstraZeneca worth $4.46M as of Q3 2026.
  • Benjamin Edwards bought 279 AstraZeneca shares in Q3 2026, an estimated $46.5K.
  • AstraZeneca made up 0.04% of Benjamin Edwards's portfolio in Q3 2026, its #376 holding.
  • Benjamin Edwards first reported a position in AstraZeneca in Q1 2020 and has held it in 27 quarters since.
  • Benjamin Edwards's AstraZeneca position peaked at $5.66M in Q1 2026.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.